Physician profile
Eric Todd Morrison
NPI 1962930495
$1,331.70
in general payments reported to CMS, 2019-2025
15 companies · $9.75 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $196 · 2021: $229 · 2022: $307 · 2025: $9.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $370.08 | 2019-2022 | |
| Kci USA, INC. | $177.62 | 2019-2020 | |
| Intuitive Surgical, INC. | $175.66 | 2020-2025 | |
| Cordis US Corp. | $86.01 | 2022 | |
| Integra Lifesciences Corporation | $76.75 | 2019 | |
| Convatec INC. | $67.40 | 2019 | |
| Baxter Healthcare | $66.43 | 2019 | |
| Medtronic, INC. | $64.58 | 2021 | |
| Medical Device Business Services, INC. | $61.89 | 2022 | |
| Innocoll Pharmaceuticals Limited | $61.27 | 2021-2022 | |
| Cardinal Health 200 LLC | $57.52 | 2019 | |
| Pfizer INC. | $22.96 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $19.75 | 2021 | |
| Ethicon US, LLC | $12.60 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.